alpha-丙氧基苯乙醇 | 71648-33-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: alpha-丙氧基苯乙醇
• 中文别名: α-丙氧基苯乙基醇
• 英文名称: alpha-Propoxyphenethyl alcohol
• 英文别名: 2-phenyl-1-propoxyethanol
• CAS: 71648-33-4
• 化学式: C₁₁H₁₆O₂
• 分子量: 180.24
• InChiKey: ZIIZEEWHNOONMF-UHFFFAOYSA-N

物化性质

• 沸点：
  219.7±20.0 °C(Predicted)
• 密度：
  1.023±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• 4-Imidazoline derivatives and their use in preparing pharmaceutical compositions
  申请人：MITSUBISHI KASEI CORPORATION

  公开号：EP0396973A1

  公开（公告）日：1990-11-14

  4-lmidazoline derivatives represented by the formula (I) and/or formula (II): wherein R1 represents C1-C8 alkyl, C3-C8 alkenyl, C3-Cs alkynyl, C3-C8 cycloalkyl, or optionally substituted aralkyl; R2 and R3 independently represent hydrogen, C3-C20 alkyl, C3-C20 alkenyl, C3-C20 alkynyl, C3-C20 alkoxy, C3-C20 alkenyloxy, C3-C20 alkynyloxy, C3-CS cycloalkyl, C1-C10 alkylthio, or optionally substituted aralkyl or aralkyloxy; R4 represents C1-C6 alkyl, C3-C8 cycloalkyl, or optionally substituted aralkyl; provided that R2 and R3 cannot be hydrogen at the same time, and pharmaceutically acceptable salts thereof. A pharmaceutical formulation containing the compound is also provided.

  由式 (I) 和/或式 (II) 代表的 4-咪唑啉衍生物： 其中 R1 代表 C1-C8 烷基、C3-C8 烯基、C3-Cs 炔基、C3-C8 环烷基或任选取代的芳烷基；R2 和 R3 独立地代表氢、C3-C20 烷基、C3-C20 烯基、C3-C20 炔基、C3-C20 烷氧基、C3-C20 烯氧基、C3-C20 炔氧基、C3-CS 环烷基、C1-C10 硫代烷基或任选取代的芳烷基或芳烷氧基； R4 代表 C1-C6 烷基、C3-C8 环烷基或任选取代的芳烷基；但 R2 和 R3 不能同时为氢，以及其药学上可接受的盐。 还提供了含有该化合物的药物制剂。
• CYCLIC COMPOUNDS AND USES THEREOF
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1182195A1

  公开（公告）日：2002-02-27

  Compounds of general formula (1) or salts thereof, exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group represented by, e. g., general formula (2) (wherein A and B are each an optionally substituted five-to seven-membered ring; E1 and E4 are each optionally substituted carbon or the like; E2 and E3 are each oxygen or the like; and a and b are each a single bond or a double bond); X2 is a divalent group constituting a straight chain moiety; Z1 is a divalent cyclic group or the like; Z2 is a free valency or the like; and R2 is optionally substituted amino or the like.

  通式(1)化合物 或其盐类，对 HIV 感染性疾病具有预防和治疗作用 其中 R1 是任选取代的五元或六元环基；X1 是游离价或类似物；W 是二价基团，如通式（2）所代表的二价基团。 (其中 A 和 B 分别为任选取代的五至七元环；E1 和 E4 分别为任选取代的碳或类似物；E2 和 E3 分别为氧或类似物；以及 a 和 b 分别为单键或双键）；X2 为构成直链分子的二价基团；Z1 为二价环状基团或类似物；Z2 为自由价或类似物；以及 R2 为任选取代的氨基或类似物。
• LIQUID CRYSTAL DISPLAY ELEMENT, POSITIVE TYPE RADIATION SENSITIVE COMPOSITION, INTERLAYER INSULATING FILM FOR LIQUID CRYSTAL DISPLAY ELEMENT, AND FORMATION METHOD THEREOF
  申请人：ICHINOHE Daigo

  公开号：US20110281040A1

  公开（公告）日：2011-11-17

  Provided by the present invention is a liquid crystal display element including: two substrates disposed oppositely, an interlayer insulating film laminated on the inner face side of at least one of the substrates, and a liquid crystal layer being provided between the substrates, and being formed from a polymerizable liquid crystal composition, in which a resin constituting the interlayer insulating film has a crosslinking moiety of a polymer represented by the following formula (1):
• US5116858A
  申请人：——

  公开号：US5116858A

  公开（公告）日：1992-05-26
• US6627651B1
  申请人：——

  公开号：US6627651B1

  公开（公告）日：2003-09-30